Optas, LLC
- SEC CIK
- 0001802961
- Latest filing
- Jul 21, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Optas, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −7,674−100.0% | Sold out | Holders |
| Q1 2026 | 7,674 | $282.0K | <0.1% | +1,811+30.9% | Added | Holders |
| Q4 2025 | 5,863 | $298.3K | <0.1% | +642+12.3% | Added | Holders |
| Q3 2025 | 5,221 | $289.7K | <0.1% | +28+0.5% | Added | Holders |
| Q2 2025 | 5,193 | $358.4K | 0.1% | −126−2.4% | Reduced | Holders |
| Q1 2025 | 5,319 | $369.4K | 0.1% | −940−15.0% | Reduced | Holders |
| Q4 2024 | 6,259 | $538.4K | 0.1% | +614+10.9% | Added | Holders |
| Q3 2024 | 5,645 | $672.1K | 0.2% | −118−2.0% | Reduced | Holders |
| Q2 2024 | 5,763 | $822.6K | 0.2% | +43+0.8% | Added | Holders |
| Q1 2024 | 5,720 | $734.4K | 0.2% | +16+0.3% | Added | Holders |
| Q4 2023 | 5,704 | $590.1K | 0.2% | +286+5.3% | Added | Holders |
| Q3 2023 | 5,418 | $492.7K | 0.2% | +152+2.9% | AddedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 2,633 | $426.1K | 0.1% | +78+3.1% | Added | Holders |
| Q1 2023 | 2,555 | $406.6K | 0.1% | +120+4.9% | Added | Holders |
| Q4 2022 | 2,435 | $329.6K | 0.1% | +11+0.5% | Added | Holders |
| Q3 2022 | 2,424 | $242.0K | 0.1% | +70+3.0% | Added | Holders |
| Q2 2022 | 2,354 | $263.0K | 0.1% | +227+10.7% | Added | Holders |
| Q1 2022 | 2,127 | $236.0K | 0.1% | +2,127 | New | Holders |